ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Long Term Debt 2017–2025
ImmuCell Corporation annual/quarterly long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- ImmuCell Corporation long term debt for the quarter ending December 31, 2025 were 9.1M, a 0.64% increase year-over-year.
- ImmuCell Corporation long term debt for 2025 were 9.1M, a 0.64% increase from 2024.
- ImmuCell Corporation long term debt for 2024 were 9.0M, a 11.63% decrease from 2022.
- ImmuCell Corporation long term debt for 2022 were 10.2M, a 1159.60% increase from 2021.
- ImmuCell Corporation long term debt for 2021 were 812,207.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| ImmuCell Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $9 |
| 2024 | $9 |
| 2022 | $10 |
| 2021 | $1 |
| 2020 | $9 |
| 2019 | $8 |
| 2018 | $9 |
| 2017 | $9 |
| ImmuCell Corporation Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $9 |
| 2024-12-31 | $9 |
| 2022-12-31 | $10 |
| 2021-12-31 | $1 |
| 2020-12-31 | $9 |
| 2019-12-31 | $8 |
| 2018-12-31 | $9 |
| 2017-12-31 | $9 |
ImmuCell Corporation Long Term Debt — FAQ
ImmuCell Corporation (ICCC) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's long term debt history?
The chart and table above show ImmuCell Corporation's long term debt by year and by quarter, including the growth rate.